Monthly Archives: March 2011

BREAKING – Latest Statement from FDA on the Draft Guidance on the Internet and Social Media

In response to inquiry about the status of the FDA’s Draft Guidance on the Internet and Social Media, originally set for release by the end of 2010 and reset to aim for the first quarter of 2011, the agency responded … Continue reading

Posted in Uncategorized | 11 Comments

FDA Funding – When the Audience Changes, the Message Must Change

On March 11, Dr. Margaret Hamburg presented testimony before the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies regarding funding for the FDA.  Her remarks did a capable job of outlining what the FDA does and … Continue reading

Posted in FDA Image, Finance, Legislation | 1 Comment

What the FDA Social Media Guidance Must Address

As March progresses, increasing numbers of social media observers, communications professionals and marketers of medical products are left wondering whether or not the FDA will produce the Draft Guidance on the Internet and Social Media by its (second) deadline of … Continue reading

Posted in FDA Policy, New and Social Media, Social Media | 3 Comments

What Would it Take to Make a Great Pharma YouTube Channel?

As an industry, Pharma has not done a good job on YouTube.  Most of the channels have malnourished content and appear as if they were an untended garden.  Other industries have gone to great lengths to connect with their consumers … Continue reading

Posted in New and Social Media, Social Media | Comments Off on What Would it Take to Make a Great Pharma YouTube Channel?

Weekly Roundup 3/4/11

Well, the government didn’t shut down today.  The way that it was covered in the media, the fact that Congress and the Administration averted a shut down by agreeing to a two-week Continuing Resolution, you would have thought they really … Continue reading

Posted in Uncategorized | Comments Off on Weekly Roundup 3/4/11